Cantel Medical Corp. (NYSE:CMN) posted its quarterly earnings results on Thursday. The company reported $0.48 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.11. Cantel Medical Corp. had a net margin of 9.02% and a return on equity of 16.70%. The business earned $179 million during the quarter. During the same period last year, the company earned $0.39 EPS. The business’s quarterly revenue was up 18.3% on a year-over-year basis.
Cantel Medical Corp. (NYSE:CMN) opened at 77.98 on Monday. Cantel Medical Corp. has a 52-week low of $52.23 and a 52-week high of $81.63. The company’s 50 day moving average is $76.26 and its 200-day moving average is $70.71. The stock has a market cap of $3.23 billion, a PE ratio of 57.04 and a beta of 1.59.
CMN has been the subject of several analyst reports. Benchmark Co. initiated coverage on shares of Cantel Medical Corp. in a research note on Monday, August 29th. They issued a “buy” rating and a $83.00 price target for the company. Needham & Company LLC started coverage on shares of Cantel Medical Corp. in a research report on Wednesday, August 24th. They set a “hold” rating for the company.
Hedge funds have recently made changes to their positions in the stock. Acrospire Investment Management LLC boosted its stake in shares of Cantel Medical Corp. by 51.2% in the second quarter. Acrospire Investment Management LLC now owns 1,477 shares of the company’s stock valued at $102,000 after buying an additional 500 shares during the period. LS Investment Advisors LLC boosted its position in shares of Cantel Medical Corp. by 7.5% in the second quarter. LS Investment Advisors LLC now owns 1,510 shares of the company’s stock worth $104,000 after buying an additional 106 shares during the last quarter. BlackRock Inc. boosted its position in shares of Cantel Medical Corp. by 119.5% in the first quarter. BlackRock Inc. now owns 2,355 shares of the company’s stock worth $168,000 after buying an additional 1,282 shares during the last quarter. Bank of Montreal Can acquired a new position in shares of Cantel Medical Corp. during the second quarter worth about $203,000. Finally, Cypress Wealth Advisors LLC acquired a new position in shares of Cantel Medical Corp. during the first quarter worth about $210,000. Hedge funds and other institutional investors own 81.61% of the company’s stock.
Cantel Medical Corp. Company Profile
Cantel Medical Corp. is a provider of infection prevention and control products and services in the healthcare market. The Company’s segments include Endoscopy, Water Purification and Filtration, Healthcare Disposables, Dialysis and Specialty Packaging. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.
Receive News & Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related companies with MarketBeat.com's FREE daily email newsletter.